NOVEL THERAPEUTIC TARGETS IN NEUROENDOCRINE PROSTATE CANCER

$1,170,000FY2022Defense Health AgencyDOD

Thomas Jefferson University, Philadelphia PA

Investigators

View source on USAspending →

NOVEL THERAPEUTIC TARGETS IN NEUROENDOCRINE PROSTATE CANCER · GrantIndex